1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 1:

Clinical data of 17 patients with atypical teratoid/rhabdoid tumors

Patient No./Age (y)/SexTumor LocationSurgical Resection or BiopsyDisseminated Tumor at Diagnosis/MRICSF Cytology at DiagnosisPostoperative TreatmentOutcome
1/2/FVermisTotalR+CDead
2/4/MVermisTotalR+CNo evident disease
3/10/MVermisTotalRNo evident disease
4/3.2/MCerebellar hemisphereSubtotalR+CNo evident disease
5/1.3/MMidbrainBiopsy++CDead
6/0.8/FCerebello–pontine angle cisternSubtotalCDead
7/5/MFrontal lobePartial+R+CDead
8/3.4/FFrontal lobeSubtotalR+CDead
9/4/MFrontal lobePartialR+CDead
10/4/FSeptum pellucidumSubtotalR+CDead
11/0.7/FPinealSubtotalCDead
12/0.3/FPineal–midbrain–cerebellumBiopsyNoneDead
13/0.8/MPineal–midbrain–cerebellumBiopsy++NoneDead
14/6/FVermisTotal+R+CDead
15/15/MFrontal lobeTotalR+CNo evident disease
16/0.5/MPinealTotalCDead
17/2.5/MCervical–medullary junctionPartialCDead
  • Note:—CSF indicates cerebrospinal fluid; R, radiation therapy; C, chemotherapy.